Case Study

World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed

IQVIA and Advarra partnered to advance Operation Warp Speed COVID-19 vaccine trials and deliver exemplary service to sponsors and clinical research sites. Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to the sponsor quicker than expected.

The results:

  • IBC approval timelines reduced to under 2 working days
  • Participating sites approved 78% faster
  • Sites activated to “ready to enroll” 71% faster

To learn more, download the case study.

Are you a site looking to become a member of the Gene Therapy Ready Network? Join now

Are you a sponsor/CRO looking for a list of sites ready to conduct gene therapy research? Request a Gene Therapy Ready site list

Who should watch?

text goes here

CEU Credits

text goes here

Certificate of Attendance

text goes here

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Access Now